收藏切换
Application of ginkgo leaf extract and armillaria mellea powders oral solution after percutaneous coronary intervention in patients with coronary atherosclerotic heart disease with blood stasis syndrome combined with type 2 diabetes mellitus
收藏切换
Jing WANG, Junhong DOU
World Clinical Drug | 2025, 46(8) : 823 - 829
Less
收藏切换
World Clinical Drug | 2025, 46(8): 823-829
Application of ginkgo leaf extract and armillaria mellea powders oral solution after percutaneous coronary intervention in patients with coronary atherosclerotic heart disease with blood stasis syndrome combined with type 2 diabetes mellitus
Full
Jing WANG, Junhong DOU
Affiliations
  • Department of Cardiology, Shuangqiao Hospital, Chaoyang District, Beijing 100024, China
Published: 2025-08-10 doi: 10.13683/j.wph.2025.08.014
Outline
收藏切换
Objective

To investigate the effects of ginkgo leaf extract and armillaria mellea powders oral solution in coronary atherosclerotic heart disease(CAHD) with blood stasis syndrome combined with diabetes mellitus after percutaneous coronary intervention(PCI).

Methods

A total of 94 patients with CAHD and diabetes mellitus admitted to the Department of Cardiology, Shuangqiao Hospital, Chaoyang District, Beijing from January 2021 to November 2021 were selected. All patients received PCI treatment and were randomly divided into the control group(n=47, receiving conventional treatment) and the experimental group(n=47, receiving conventional treatment plus ginkgo leaf extract and armillaria mellea powders oral solution) through matched randomization. The differences of oxidative stress indexes,immune function indexes and serum cystatin(Cys)C expression levels before and after treatment were compared between the two groups.

Results

The expression levels of superoxide dismutase and glutathione peroxidase in experimental group were significantly higher than those in control group after treatment(P<0.05). The expression levels of immunoglobulin(Ig)G, interleukin-6 and IgM in experimental group were significantly higher than those in control group after treatment(P<0.05). The expression level of serum CysC in experimental group after treatment was significantly lower than that in control group(P<0.05). The clinical efficacy of the experimental group was higher than that of control group(91.49% vs. 73.91%, P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).

Conclusion

Ginkgo leaf extract and armillaria mellea powders oral solution can significantly improve the oxidative stress response and immune function of patients with CAHD complicated with diabetes after PCI, reduce the level of serum CysC, improve the clinical efficacy, and can be widely applied in clinical practice.

ginkgo leaf extract and armillaria mellea powders oral solution  /  percutaneous coronary intervention  /  coronary atherosclerotic heart disease  /  diabetes mellitus  /  cystatin C  /  oxidative stress  /  immune response
王竞, 窦俊红. 银杏蜜环口服液在冠状动脉粥样硬化性心脏病血瘀证合并2型糖尿病经皮冠脉介入术后的应用. 世界临床药物, 2025 , 46 (8) : 823 -829 . DOI: 10.13683/j.wph.2025.08.014
Jing WANG, Junhong DOU. Application of ginkgo leaf extract and armillaria mellea powders oral solution after percutaneous coronary intervention in patients with coronary atherosclerotic heart disease with blood stasis syndrome combined with type 2 diabetes mellitus[J]. World Clinical Drug, 2025 , 46 (8) : 823 -829 . DOI: 10.13683/j.wph.2025.08.014
Year 2025 volume 46 Issue 8
95
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.08.014
  • Receive Date:2025-04-03
  • Online Date:2026-11-09
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-04-03
Affiliations
    Department of Cardiology, Shuangqiao Hospital, Chaoyang District, Beijing 100024, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.08.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT